drugset / Trial / NCT04602221
A Study in Healthy Men to Test Whether BI 409306, BI 425809 or Lamotrigine Can Reverse the Memory Problems Caused by Ketamine
RandomizedCrossoverTriple-blindTreatment
Summary
The main objective of this trail is to investigate if and to what extent BI 409306, BI 425809 and lamotrigine attenuate ketamine induced cognitive deficits.
Timeline
- Start
- 2020-12-01
- Primary completion
- 2022-08-01
- Completion
- 2022-08-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iclepertin | Small molecule | — | — |
| Subject | Lamotrigine | Small molecule | — | — |
| Subject | OSORESNONTRINE | Small molecule | — | — |
Indications
No indication recorded.